Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?

Naseer, Maliha; Poola, Shiva; Ali, Syed; Samiullah, Sami; Tahan, Veysel

Naseer, Maliha; Poola, Shiva; Ali, Syed; Samiullah, Sami; Tahan, Veysel.

Afiliação

Naseer M; Division of Gastroenterology & Hepatology, Department of Internal Medicine, East Carolina University, Greenville, NC 27834, United States.
Poola S; Department of Internal and Pediatric Medicine, East Carolina University, Greenville, NC 27834, United States.
Ali S; Department of Internal Medicine, University of Missouri, Columbia, MO 65211, United States.
Samiullah S; Assistant Professor of Clinical Medicine, University of Missouri, Division of Gastroenterology and Hepatology, Columbia, MO 65211, United States.
Tahan V; Assistant Professor of Clinical Medicine, University of Missouri, Division of Gastroenterology and Hepatology, Columbia, MO 65211, United States.

Curr Clin Pharmacol ; 15(3): 216-233, 2020.

Article em En | MEDLINE | ID: mdl-32164516

Assuntos

Colite Ulcerativa/terapia; Doença de Crohn/terapia; Prebióticos/administração & dosagem; Probióticos/administração & dosagem; Animais; Colite Ulcerativa/microbiologia; Doença de Crohn/microbiologia; Microbioma Gastrointestinal/fisiologia; Humanos; Pouchite/microbiologia; Pouchite/terapia; Indução de Remissão

Palavras-chave

Crohn's Disease (CD); Prebiotics; inflammatory bowel disease; pouchitis; probiotics; ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Doença de Crohn / Probióticos / Prebióticos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google